Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 125Terminated 15Unknown 14Active not recruiting 9Withdrawn 4Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 158INDUSTRY 122NIH 16OTHER_GOV 5NETWORK 2UNKNOWN 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 1

Conditions

Metastatic Small Intestinal Adenocarcinoma 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Specimen Handling 39Magnetic Resonance Spectroscopy 30Carboplatin 14Biopsy 14Radiation 13Cyclophosphamide 13Radiotherapy 11daratumumab 10Vincristine 10Dexamethasone 10Surgical Procedures, Operative 9Etoposide 9Lenalidomide 8X-Rays 7Observation 7Leucovorin 7Irinotecan 7Doxorubicin 7Cisplatin 7durvalumab 6dexamethasone acetate 6dexamethasone 21-phosphate 6auricularum 6Watchful Waiting 6Radiosurgery 6Docetaxel 6Calcium Dobesilate 6pembrolizumab 5Stem Cell Transplantation 5Standard of Care 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × NETWORK × Paclitaxel × Clear all
NCT04205968 2025-11-05

Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers

SWOG Cancer Research Network

Phase 2 Recruiting
94 enrolled

Metastatic Small Intestinal Adenocarcinoma

NCT05929768 2025-11-05

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

SWOG Cancer Research Network

Phase 3 Recruiting
2,400 enrolled
Breast

Anatomic Stage I Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡